Skip to main content
Premium Trial:

Request an Annual Quote

BioCommerce Week s Index to the Diversified Molecular Biology Tools Companies: Oct 28, 2004

 

Harvard Bioscience Recovers Some Ground, Agilent Spurts

Shares of Harvard Bioscience and Agilent Technologies improved 7 percent for the five-day period as the BioCommerce Week Index ended down for the fourth time in the last five weeks.

The stock of Harvard Bioscience, which reports its third-quarter financials on Friday, has lost 12 percent of its market capitalization over the last three weeks. The company recovered some ground this week after its shares neared a 52-week low last week on a downturn that started when its shares fell 45 percent following the release of the company’s Q1 results, highlighting earnings shortfalls at its Genomics Solutions unit.

Agilent, which closed at $24.33, up from $22.72 last week, was one of six BCW Index companies - Harvard Bio, BD, General Electric, Applied Biosystems, and PerkinElmer — whose shares finished up for the five-day period. Bruker closed Tuesday at $3.20, remaining unchanged for the week.

Waters, which reported earnings on Tuesday, fell 7 percent, closing at $39.19, down from last week’s $42.15, to lead stock-price losers.

The BCW index closed at $31.11, down 1 percent from last week’s $31.44. The Amex Biotech and Pharmaceutical indexes were down just under 2 percent for the five-day period, while the Dow Jones Industrials was up a fraction, and the S&P 500 and Nasdaq indexes were up a fraction under 1 percent up for the week.

Following is a list of when the BCW Index companies will report their financials for the quarter ending Sept. 30:

  • Agilent Q4 2004: Nov. 11
  • Becton Dickinson Q4 2004: Nov. 4
  • Beckman Coulter Q3 2004: Oct. 29
  • Bio-Rad Q3 2004: Nov. 4
  • Bruker Q3 2004: Nov. 3
  • Harvard Biosciences Q3 2004: Oct. 29
  • Invitrogen Q3 2004: Oct. 28
  • Molecular Devices Q3 2004: Oct. 29
  • PerkinElmer Q3 2004: Oct. 29
  • Stratagene Q3 2004: Nov. 8

 

File Attachments
The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.